DE69500511D1 - Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis - Google Patents

Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis

Info

Publication number
DE69500511D1
DE69500511D1 DE69500511T DE69500511T DE69500511D1 DE 69500511 D1 DE69500511 D1 DE 69500511D1 DE 69500511 T DE69500511 T DE 69500511T DE 69500511 T DE69500511 T DE 69500511T DE 69500511 D1 DE69500511 D1 DE 69500511D1
Authority
DE
Germany
Prior art keywords
epidermis
proliferative diseases
treatment
phosphate diesters
diesters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69500511T
Other languages
English (en)
Other versions
DE69500511T2 (de
Inventor
Kazumi Ogata
Rie Nagao
Takahiro Sakaue
Shinya Ogino
Sachiko Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69500511D1 publication Critical patent/DE69500511D1/de
Application granted granted Critical
Publication of DE69500511T2 publication Critical patent/DE69500511T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69500511T 1994-04-22 1995-04-13 Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis Expired - Fee Related DE69500511T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8424894 1994-04-22

Publications (2)

Publication Number Publication Date
DE69500511D1 true DE69500511D1 (de) 1997-09-11
DE69500511T2 DE69500511T2 (de) 1998-01-02

Family

ID=13825166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69500511T Expired - Fee Related DE69500511T2 (de) 1994-04-22 1995-04-13 Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis

Country Status (6)

Country Link
EP (1) EP0679399B1 (de)
KR (1) KR950031085A (de)
AT (1) ATE156359T1 (de)
DE (1) DE69500511T2 (de)
ES (1) ES2107279T3 (de)
TW (1) TW287103B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209690A1 (en) * 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1420797A4 (de) * 2001-07-27 2005-03-02 Vital Health Sciences Pty Ltd Hauttherapie unter verwendung von phosphatderivaten von elektronentransfermitteln
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
ES2557475T3 (es) * 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
KR20080085839A (ko) * 2005-12-23 2008-09-24 바이탈 헬스 사이언시즈 피티와이 리미티드 사이토킨 조절 특성을 가진 화합물
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
US5122536A (en) * 1989-10-12 1992-06-16 Perricone Nicholas V Method for the topical treatment of psoriasis

Also Published As

Publication number Publication date
KR950031085A (ko) 1995-12-18
TW287103B (de) 1996-10-01
ES2107279T3 (es) 1997-11-16
ATE156359T1 (de) 1997-08-15
EP0679399B1 (de) 1997-08-06
EP0679399A1 (de) 1995-11-02
DE69500511T2 (de) 1998-01-02

Similar Documents

Publication Publication Date Title
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
DE69815527D1 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
DE69500511D1 (de) Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis
DE69334250D1 (de) Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
ATE280577T1 (de) Oxa-säuren und verwandte verbindungen zur behandlung von störungen der haut
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
ES2114870T3 (es) Nuevos derivados de mercaptoacetilamida utiles como inhibidores de encefalinasa y eca.
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE69019111D1 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
MX9203945A (es) Esteres bisfosfonicos de pirazolpirimidina y pirimidinilo como antiinflamatorios
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
DE69506197D1 (de) Verwendung eines Ascorbyl-tocopherylphosphats zur Herstellung eines Arzneimittels zur Behandlung der Pankreatitis
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
ATE101040T1 (de) Derivate und analoge von pyrimidon zur behandlung von asthma und bestimmte hautkrankheiten.
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
PT916666E (pt) 3-alquiloxi- ariloxi- ou arilalquiloxi-benzo¬b|tiofeno-2-carboxamidas como inibidores de adesao celular
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
DE69026991D1 (de) Phospholipide zur Behandlung der multiplen Sklerose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee